← All trials
NCT04614909
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 31, 2020
- Primary completion
- Sep 30, 2021
- Completion date
- Dec 31, 2023
- First posted
- Nov 4, 2020
- Last posted
- Dec 31, 2020
- Enrollment
- 30
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Barrow Neurological InstituteLead sponsor
- BeOne MedicinesCollaborator
- University of ArizonaSponsor investigator
- Barrow Neurological InstituteCollaborator
- Ivy Brain Tumor CenterCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.